These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 25041220

  • 1. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
    Lo CH, Huang WY, Lin KT, Lin MJ, Lin TP, Jen YM.
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization.
    Lo CH, Huang WY, Lee MS, Lin KT, Lin TP, Chang PY, Fan CY, Jen YM.
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):345-52. PubMed ID: 24384685
    [Abstract] [Full Text] [Related]

  • 3. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):355-61. PubMed ID: 22342300
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
    Yang JF, Lo CH, Lee MS, Lin CS, Dai YH, Shen PC, Chao HL, Huang WY.
    Radiat Oncol; 2019 Oct 22; 14(1):180. PubMed ID: 31640728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):486-93. PubMed ID: 20350791
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Su TS, Liang P, Liang J, Lu HZ, Jiang HY, Cheng T, Huang Y, Tang Y, Deng X.
    Int J Radiat Oncol Biol Phys; 2017 Jul 01; 98(3):639-646. PubMed ID: 28581406
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e447-53. PubMed ID: 21645977
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY, Lee Y, McLean K, Leggett D, Hodgkinson P, Fawcett J, Mott R, Stuart K, Pryor D.
    Clin Oncol (R Coll Radiol); 2020 Oct 15; 32(10):e194-e202. PubMed ID: 32345457
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.